RT Journal Article
SR Electronic
T1 Two years later – changes in abdominal organs: First observations from the UK Biobank longitudinal imaging study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.08.29.21262790
DO 10.1101/2021.08.29.21262790
A1 Whitcher, Brandon
A1 Thanaj, Marjola
A1 Cule, Madeleine
A1 Liu, Yi
A1 Basty, Nicolas
A1 Sorokin, Elena P.
A1 Bell, Jimmy D.
A1 Thomas, E. Louise
YR 2021
UL http://medrxiv.org/content/early/2021/09/07/2021.08.29.21262790.abstract
AB Longitudinal studies provide unique insights into the impact of environmental factors and lifespan issues on health and disease. Here we investigate changes in body composition in 3,088 free-living participants, part of the UK Biobank in-depth imaging study. All participants underwent neck-to-knee MRI scans at baseline and after approximately two years (re-imaging). Image-derived phenotypes for each participant were extracted using a fully-automated image processing pipeline, including volumes of several tissues and organs: liver, pancreas, spleen, kidneys, total skeletal muscle, iliopsoas muscle, visceral adipose tissue (VAT), abdominal subcutaneous adipose tissue (ASAT), as well as fat and iron content in liver, pancreas and spleen. Overall, no significant changes were observed in BMI, body weight, or waist circumference over the scanning interval, despite some large individual changes. A significant decrease in grip strength was observed, coupled to small, but statistically significant, decrease in all skeletal muscle measurements. Significant increases in VAT and intermuscular fat in the thighs were also detected in the absence of changes in BMI, waist circumference and ectopic-fat deposition. Adjusting for disease status at baseline did not have an additional impact on the changes observed. In summary, we show that even after a relatively short period of time significant changes in body composition can take place, probably reflecting the obesogenic environment currently inhabited by most of the general population in the United Kingdom.Competing Interest StatementMC and EPS are employees of Calico Life Sciences LLC. YL was an employee of Calico Life Sciences LLC. BW, MT, NB, JDB and ELT declare no competing interests.Funding StatementThis study was funded by Calico Life Sciences LLC. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Participant data from the UKBB cohort was obtained as previously described through UKBB Access Application number 44584. The UKBB has approval from the North West Multi-Centre Research Ethics Committee (REC reference: 11/NW/0382). All methods were performed in accordance with the relevant guidelines and regulations, and informed consent was obtained from all participants.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesResearchers may apply to use the UKBB data resource by submitting a health-related research proposal that is in the public interest. More information may be found on the UKBB researchers and resource catalogue pages (www.ukbiobank.ac.uk).